Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 654-657, February 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niitsu, Y.
Right arrow Articles by Urushizaki, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niitsu, Y.
Right arrow Articles by Urushizaki, I.

Synergistic Effects of Recombinant Human Tumor Necrosis Factor and Hyperthermia on in Vitro Cytotoxicity and Artificial Metastasis

Yoshiro Niitsu, Naoki Watanabe, Hiroshi Umeno, Hisao Sone, Hiroshi Neda, Naofumi Yamauchi, Masahiro Maeda and Ichiro Urushizaki

Department of Internal Medicine (Section 4), Sapporo Medical College, South-1, South-1, West-16, Chu-ku, Sapporo, Japan

Synergy in cytotoxic effect between recombinant human tumor necrosis factor and hyperthermia (incubation at 38.5°C or 40°C) was observed to occur against L-M (mouse tumorigenic fibroblast) cells and shown to be related to an accelerated turnover rate of recombinant human tumor necrosis factor-receptor complex under elevated temperatures rather than to changes in number of cell receptors or binding strength. However, no synergy in cytotoxic effect was observed to occur against human embryonic lung (HEL) cells.

A clearly synergistic inhibition of metastatic tumor growth by combined administration of recombinant human tumor necrosis factor (300 units) and whole-body hyperthermia (40°C, 30 min) was also observed in BALB/c mice previously given injections of 1 x 106 Meth-A (MH) cells/mouse via tail vein, neither of which alone resulted in significant inhibition.

Received 6/26/87. Revised 10/ 1/87. Accepted 10/27/87.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
U. F.W. Franke, T. Wittwer, M. Lessel, K. Liebing, M. Albert, V. Becker, H. Schubert, and T. Wahlers
Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I. Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity
Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 792 - 799.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. I. Pass, D. J. Y. Mew, K. C. Kranda, B. K. Temeck, J. S. Donington, and S. A. Rosenberg
Isolated Lung Perfusion With Tumor Necrosis Factor for Pulmonary Metastases
Ann. Thorac. Surg., June 1, 1996; 61(6): 1609 - 1617.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.